Lotus Ventures (the “Company”) (CSE:J) is approaching completion of its initial 22,500 square feet facility and anticipates submission of its evidence package in November. Design work and building permit drawings for the expansion of the facility by an additional 28,000 – 30,000 square feet is almost complete. The company will provide an update on the expansion budget, estimated capacity and timeline shortly after permit drawings are complete.

Lotus Ventures has retained IF Communications for assistance in the company’s packaging and branding of Lotus’ strains. The company executives and production staff including Head Grower and First Grower identified the groups dedication to reliable production of premium cannabis products. The company is well aware of the North Okanagan’s tradition of producing top-quality medical and recreational marijuana, and in a wide variety of specialized strains.


The Lotus brand approach will express the enhancement of plant health and growing conditions through authentic cultivation processes, and the best technology on environmental and sanitation controls. These technologies also enable low production costs for a premium product.

Further to the news release of October 15, 2018, the company has closed a third tranche of its non-brokered private placement financing by issuance of 2,800,000 units at a price of $0.25 per unit for gross proceeds of $700,000. Each unit consists of one common share and one transferrable share purchase warrant, each warrant exercisable to purchase one common share at $0.30 per share for five years. Securities issued pursuant to the financing are subject to a four-month hold period under applicable Canadian securities law. Total proceeds from the placement, announced Sept. 11, 2018, was an aggregate of $2,815,000 and 11,260,000 units issued. The proceeds from the Offering will be used for working capital and general corporate purposes.

ON BEHALF OF THE BOARD

Lotus Ventures Inc.

“Dale McClanaghan”
Dale McClanaghan, President and CEO

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-9844 or Daniel McRobert, Communications danielmcrobertt@gmail.com (604) 842-4625

Forward-Looking Information

This news release may contain certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projection contained in the forward-looking information throughout this news release. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Click here to connect with Lotus Ventures (the “Company”) (CSE:J) for an Investor Presentation.

Source: www.lotusventures.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less